All Editorial articles
View all stories of the same content type.
-
EditorialThe innovation era: Where biology meets technology
This issue highlights the rapid evolution of the biologicals landscape and shows why early, transparent regulatory dialogue is now critical to translating scientific breakthroughs into global patient access.
-
EditorialMedTech in transition: Regulation, risk and real-world impact
This issue is shaped by a unifying theme: how risk, evidence, inclusivity and innovation are being brought to the forefront by evolving regulatory expectations across the medical device lifecycle.
-
EditorialNavigating complexity: Regulation at the interface of innovation, technology and confidence
This issue focuses on complex products, with articles on brain-computer interfaces, radiopharmaceuticals and sophisticated generic products, and explores how regulatory systems can remain robust and predictable while enabling novel technologies to reach patients.
-
EditorialNorth America: Transparency, transformation and innovation pathways
This issue focuses on North America, with articles centring on developments in both the US and Canada. It also presents multiple articles on the topic of medical devices and technology.
-
EditorialTOPRA Symposium 2025: Leading with impact
This issue reports on the human medicine, medical device, IVD and veterinary medicine sessions from the 2025 TOPRA Symposium.
-
EditorialFrom trials to approval: Regulatory strategies in early drug development
This issue focuses on the acceleration of early drug development, the opportunities and challenges that this brings and strategic guidance for regulatory professionals.
-
EditorialReimagining product information
This issue delves into the fundamental role of product information and the processes for its management, and explores how technological advancements are shaping its evolution, with patients’ needs at its core.
-
EditorialPatient voice: Shaping the future of medicine regulation
This issue looks at the evolving landscape of public and patient involvement (PPI) and how the views of the patient community are being included in research, academia, health and social care and regulatory decision-making.
-
EditorialVeterinary medicines: Translating regulation into practice
This issue looks at the impact of the Veterinary Regulation 2019/6, the effect of the new EMA fees on marketing authorisation holders, and the regulatory challenges associated with the practical use of bacteriophages in veterinary medicine.
-
EditorialAdvanced therapies: A maturing regulatory framework
This issue looks at CMC requirements, recent therapeutic innovations in the oncology field, and the complex interconnection between ATMPs and in vitro diagnostic medical devices.
-
-
-
-
-
-
-
-
-
EditorialSustainable pharmaceuticals
Regulatory Rapporteur July/August 2024 | Volume 21 | No.7 In this bumper July/August edition of Regulatory Rapporteur, we focus on sustainability and, in many aspects, we build upon our June theme of access to medicines. Sustainability in pharmaceuticals encompasses ...
-
EditorialThe global access battle for healthcare equity
Regulatory Rapporteur June 2024 | Volume 21 | No.6 The World Health Organization (WHO) has estimated that one-third of the global population lacks regular access to essential medicines. The concept of access to medicines will likely resonate differently within ...